ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 208885 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 208885; 2) Community: the network communities that were significantly associated with the response to NSC 208885; 3) Molecule: the relationships between components within communities and NSC 208885; 4) MDR: the compounds that were significantly associated with the NSC 208885.

NSC Compound Enrichment Correlation
NSC 7821 [6-(Dimethylamino)-3H-phenoxazin-3-ylidene]dimethylammonium chloride 0.0137891122538509 0.4535919
NSC 87221 Actinomycin D, 2A-D-alloisoleucine- (9CI) 0.0137891122538509 0.29129465
NSC 88916 10,13-dimethyl-17-(2-methyl-1,3-thiazol-4-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one 0.0137891122538509 0.11218703
NSC 8985 WLN: 1R D-I-R D1 &E &6/14 0.0137891122538509 0.59156867
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.013789112253851 0.41173151
NSC 166382 Null 0.013789112253851 0.12027671
NSC 109084 Null 0.0171490505199911 0.26958033
NSC 117281 ANTINEOPLASTIC-117281 0.0171490505199911 0.31214602
NSC 134033 Aminopterin Derivative 0.0171490505199911 -0.17674163
NSC 201863 N-[1-(Biphenyl-4-yl)ethyl]-3,4-dichlorobenzamide 0.0171490505199911 0.0014292774
Total:135  Current:65    [First] [Prev] [Next] [Last]